Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» BioMarin completes phase III trial enrollment for N-acetylgalactosamine 6-sulfatase for MPS IVA
BioMarin completes phase III trial enrollment for N-acetylgalactosamine 6-sulfatase for MPS IVA
BioMarin completes phase III trial enrollment for N-acetylgalactosamine 6-sulfatase for MPS IVA
Submitted by
admin
on March 10, 2012 - 6:47pm
Source:
Pharmabiz
News Tags:
Biomarin
mucopolysaccharidosis
Morquio A Syndrome
BMN-110
Headline:
BioMarin completes phase III trial enrollment for N-acetylgalactosamine 6-sulfatase for MPS IVA
Do Not Allow Advertisers to Use My Personal information
